robertpower
9 años hace
Iron Mountain Nursery BAM-FX initial test results using bamfx spray to aid in faster growth and using less water. The preliminary test results after three weeks shows a growth rate of 40% more than non-sprayed test crop. The product is amazing. We had some cold damage to our tomato crop. I sprayed with the foliar spray and after 10 days we have new 3-5” growth on the damaged stems. BAM-FX in initial testing appears to be an amazing nutritional product for plant development and health without a lot of additional fertilizer supplements.
BAM-FX™: technology brings agriculture to a new era through a patented, nutrient delivery system platform technology that allows plants to systemically absorb almost any mineral from the soil, improving survivability and nutritive value. BAM-FX™ is a balanced, super-efficient, ionized micronutrient delivery system for agriculture. BAM-FX works by enabling the systemic uptake of specific, targeted minerals and nutrients into plants, all organic and without the use of Genetic Modification. The BAM-FX formula can be applied either through the soaking of seeds or direct application at time of planting and foliar treatment of the plant at later stages of development.
http://www.imnandf.com/413491918
ZGSI-Communications
11 años hace
I wanted to update the board on some recent relevant industry news that may favorably impact our growth and development. The Center for Advancement of Science in Space (CASIS) just appointed former NASA astronaut and retired colonel, Greg Johnson, as its new executive director to take office September 1, 2013. By way of background, CASIS was chosen by NASA in 2011, as the sole manager of the International Space Station U.S. National Laboratory (ISS) with a charter to accelerate and facilitate commercialization and non-NASA research utilizing the ISS. We are delighted to see that CASIS is finalizing, after a year and a half search, the staffing of its top level management with high quality leaders who will help CASIS fulfill its charter while enabling companies like ours to realize our commercial and scientific objectives. "A rising tide floats all boats."
For more on this story, click here
TenTimesPay
11 años hace
I have no way to grant you the spot. If you post a couple more times with relevant information (links to things, recent PRs, anything of significance) then you can request to be a moderator. All it take is 4 posts, then you click the button towards the top that says "Add me as the moderator". I am now an investor (just took a tiny position, 100 shares) and am delighted to have you here. Can I reach you directly via the "Info@" company email, or do you have a separate email? There are only two of us active on the board currently, but I can try to round up support for the board and the company!
ZGSI-Communications
11 años hace
My name is Julie Bloch. I am Vice President, Communications at Zero Gravity Solutions, Inc. This forum was brought to our attention by one of our investors and we believe that this would be an effective venue to create a dialog between our company and the investor community. ZGSI is at the forefront of a new era of biotechnology -- zerogravity biotechnology. My purpose here will be to inform the investment community of current events, news media coverage, interviews and appearances, provide general information and updates on how we are progressing and report on relevant industry developments.
Please understand that I am bound by SEC rules and cannot talk about potential news before it has been disseminated, nor will I talk about the price potential of ZGSI as my job is to provide timely and appropriate information for investors interested in a zero gravity biotechnology company in general and ZGSI in particular.
It is our mission to be the first public company to commercialize, industrialize and monetize the unique capabilities of the ISS platform and low earth orbit. The Company is developing advances in plant, animal and human biology based on intellectual property derived from multiple experiments on the International Space Station. The Company has a platform technology and intellectual property that is aimed at developing and producing large volumes of novel stem cells with unique and beneficial characteristics in a microgravity environment, without Genetic Modification techniques, which can then be patented for commercial sale to third parties in the agricultural and medical markets. We have a highly skilled and uniquely qualified Management Team and Scientific Advisory Board that include highly regarded scientific, spaceflight operation individuals as well as experienced business and financial executives.
In addition to this forum, you can also track our progress, developments and current events on our website www.zerogsi.com and connecting with us through Facebook, Twitter @ZEROGSI and/or Google+.
Although we are primarily focused on implementing our business plan and day-to-day operations, I will be regularly monitoring and posting to this message board with current information and making every attempt to answer questions as they arise. If you have not received a response from me or would like to speak with me directly, please contact me during business hours at (561) 416-0400. Someone will always be available to answer your call.
Julie Bloch
Vice President, Communications
Zero Gravity Solutions, Inc.
(561) 416-0400
TenTimesPay
11 años hace
Zero Gravity Solution's Mission statement
Mission Statement
Our mission is to be the first company to commercialize dramatic scientific breakthroughs in the area of unique and patentable plant, animal and human stem cells developed through the ISS space station to improve life on earth.
Company Overview
Zero Gravity Solutions, Inc., (“ZGSI” or the “Company”) is a public company engaged in the development, patenting and licensing of unique stem cells produced in a zero/microgravity environment. The Company is in the process of commercializing and monetizing its significant portfolio of Intellectual Property (‘IP”), which includes patents predicting that plant and animal stem cells exposed to prolonged microgravity in space can be endowed with new characteristics extremely beneficial to mankind. In conjunction with our collaborators, NASA, the USDA and the University of Florida, we have, over the past six years, conducted scientific studies on six NASA sponsored flights to the International Space Station (ISS). These experiments have unequivocally demonstrated that the gene expression of plant cells in zero/microgravity changes substantially; furthermore, providing us with very strong evidence that these changes can be directed toward attributes of great value to mankind.
Due to the magnitude of the markets created and associated profit potential, ZGSI’s strategy is to partner and license in various ways with industry-leading companies who have the resources necessary to fully exploit the opportunities and who recognize the enormous value of having products that no one else on earth can provide.
ZGSI owns core patents pending, and is licensing many of the technologies being developed by our scientific partners. We are the first commercial developers providing results as requested by our Space Act Agreement with NASA. We are aggregating and commercializing the platform technologies essential to this new form of biotechnology. The benefits of these technologies include creating plant species that can grow and thrive in non-traditional locations -- food plants that can withstand climate change, drought and overcome other challenges. The Company’s initial commercial efforts are focused on food and energy products.
TenTimesPay
11 años hace
More on Zero Gravity Solutions Technology:
Scientific Basis
Life on Earth has always and only developed within the confines of 1G. About 50% of the energy expended by terrestrial-bound plants is dedicated to structural support, in order to overcome gravity. By removing gravity from the equation, plant cells in a weightless environment have an excess of energy causing the plant to activate its survival mechanisms. These include uninhibited and excessive gene expression. With all normally dormant genes within the cell now expressing, the plant is able to adapt quickly to a changing environment or disease-causing organism, stresses that we introduce artificially while the plant is in microgravity. This means that we can produce new varieties of plants, with commercially beneficial attributes an order of magnitude faster than traditional methods. Our technology therefore allows us to claim that we can create new patentable varieties of stem cells and plants substantially more quickly and efficiently than on Earth. It will also allow us to produce large quantities of undifferentiated cells in the same environment for commercial sale to third parties.
Platform Technology
The technologies being developed and patented with our collaborative partners and licensed by the Company comprise a proprietary new platform technology, which can provide exclusive and non-exclusive patented stem cells in large quantities to companies around the world, offering an unprecedented competitive market advantage. We will offer our potential corporate partners technology, access to space, consulting services using our expertise and strategic partners and on-orbit production of proprietary plants and stem cells. This enables us to lead this important new area of biotechnology and agricultural science. To increase earnings and reduce risk, we plan to partner and license aspects of this technology to well-established biotechnology providers and other large corporate entities worldwide.
ZGSI possesses patents pending that contain claims covering biological processes in microgravity, including the growth of cellular plant and animal tissues in orbit, the 3-Dimensional growth of biologics on-orbit, the enhanced gene expression of biologics in extended microgravity, stem cell replication and related processes. A key part of our ongoing operations is the expansion of these patents to cover additional crops, animals and humans, and the specific methods and tools that are developed from our R&D.
Directed Gene ExpressionTM
Life on Earth has always and only developed within the confines of 1G. About 50% of the energy expended by terrestrial-bound plants is dedicated to structural support, to overcome gravity. By removing gravity from the equation, plant cells in a weightless environment have an excess of energy, which allows them to express their genes in a variety of new ways that can be regulated and reproduced. We are actively moving forward with plans for new, patentable varieties such as frost and disease resistant citrus fruit trees, rice that can grow in brackish water and corn that grows with less irrigation. Future possibilities pertaining to space acquired improvements in commercial crops include bananas, papaya, fruits, wheat, and many more. The potential for space acquired improvements across a broad spectrum of commercial products is extensive.
It is important to state that our new varieties are not genetically modified with foreign genes. Our technology only directs expression of the genes that already exist, but that are dormant within the plant’s genome. Thus, our new, patentable varieties are not subject to the same common and often negative misconceptions concerning Genetic Modification (GM). We have merely accelerated genetic improvement; something that mankind has done for over 15,000 years, albeit slowly, up until now.
The ability to produce new varieties of crops addressing major challenges can be a very large business. The present system of depending on Genetically Modified crops has for example lowered USA shipments of our major crops to most countries, because many countries will not accept Genetically Modified grains and other orchard crops from the USA.
Stressing or “Directing” Gene Expression of Candidate Stem Cells
ZGSI selected Tropical Research and Education Center (“TREC”) of the Institute of Food and Agricultural Sciences (“IFAS”) at the University of Florida, Homestead to conduct the first space experiments in order to validate the efficacy of ZGSI’s technology in space. In this partnership with the University of Florida and a sponsoring commercial corporation, we have been able to prove our hypothesis of diected gene expression by flying the Jatropha stem cells in space on the Space Shuttle to the ISS. We have been able to stress the cell in space and preliminary results indicate it will have the capability of frost resistance for example and allowing the plant to be cultivated in areas that are potentially highly advantageous and profitable (like Florida).
In the case of Jatropha for bio-fuels, lands currently “scrub land”, in the West Texas oil fields, could become highly cultivated areas producing just short of 3 tons of oil, per hectare sown, five years after planting. The commercial partner on the Jatropha experiment has financed much of the cost of our space flights, proven the viability of our technology, and allowed us the proof of principle to now pursue hundreds of other species and agricultural and mammalian benefits by the use of our IP and the tools being developed by this first in space experimentation.
Additionally, our plans include patenting multiple technologies for improving the way plants and animals grow on earth. One experiment in space can yield knowledge, know-how and patents that can be used on earth for decades.
Mass Replication of New Pluripotent Stem Cells in Space
The second part of the unique space technology pertains to the mass replication of stem cells in space, something that can be done on Earth but at much slower rates than in space. Again, our six space missions have provided strong evidence supporting John Wayne Kennedy’s original hypothesis and provided initial proof-of-concept that our production of human stem cells will replicate en masse. This is a very valuable process that will allow us to produce large quantities of the required stem cells in short order. In fact, orders of magnitude quantities in much shorter times than on Earth. This segment of the IP should be of particular interest from a profit standpoint when we start to produce primordial individual human stem cells in large quantities for organ and other tissue regeneration or replacement. We should point out that billions of viable cells can be contained in a small receptacle, perhaps the size of a coffee cup. This means that our very valuable cells are high value, yet low volume products; a very attractive attribute when considering the current costs of transport to and from space.
Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
VMB-1
9 años hace
Hot Features
Premium
